These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32299208)

  • 21. Intuitive Global Insight Into COVID-19 Clinical Research Activities-The "COVID-19 Map of Hope".
    Ries M; Mechler K; Smith DL; Herfort B; Visintini J; Santana AV; Zipf A; Lautenbach S
    J Clin Pharmacol; 2020 Jul; 60(7):826-827. PubMed ID: 32437001
    [No Abstract]   [Full Text] [Related]  

  • 22. Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht).
    Tas J; van Gassel RJJ; Heines SJH; Mulder MMG; Heijnen NFL; Acampo-de Jong MJ; Bels JLM; Bennis FC; Koelmann M; Groven RVM; Donkers MA; van Rosmalen F; Hermans BJM; Meex SJ; Mingels A; Bekers O; Savelkoul P; Oude Lashof AML; Wildberger J; Tijssen FH; Buhre W; Sels JEM; Ghossein-Doha C; Driessen RGH; Kubben PL; Janssen MLF; Nicolaes GAF; Strauch U; Geyik Z; Delnoij TSR; Walraven KHM; Stehouwer CD; Verbunt JAMCF; Van Mook WNKA; van Santen S; Schnabel RM; Aries MJH; van de Poll MCG; Bergmans D; van der Horst ICC; van Kuijk S; van Bussel BCT
    BMJ Open; 2020 Sep; 10(9):e040175. PubMed ID: 32994259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research?
    Mol Cell; 2020 Jul; 79(1):9-10. PubMed ID: 32619472
    [No Abstract]   [Full Text] [Related]  

  • 24. The Wuhan SARS-CoV-2-What's next for China.
    Lu H; Stratton CW; Tang YW
    J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccine designers take first shots at COVID-19.
    Cohen J
    Science; 2020 Apr; 368(6486):14-16. PubMed ID: 32241928
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners.
    Biondi Zoccai G; Landoni G; Carnevale R; Cavarretta E; Sciarretta S; Frati G
    Minerva Cardioangiol; 2020 Apr; 68(2):61-64. PubMed ID: 32150358
    [No Abstract]   [Full Text] [Related]  

  • 28. In defense of the Unified Health System in the context of SARS-CoV-2 pandemic.
    Araújo JL; Oliveira KKD; Freitas RJM
    Rev Bras Enferm; 2020; 73 Suppl 2():e20200247. PubMed ID: 32667577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 30. Protect against market exclusivity in the fight against COVID-19.
    't Hoen E
    Nat Med; 2020 Jun; 26(6):813. PubMed ID: 32382151
    [No Abstract]   [Full Text] [Related]  

  • 31. Sarah Gilbert: carving a path towards a COVID-19 vaccine.
    Lane R
    Lancet; 2020 Apr; 395(10232):1247. PubMed ID: 32305089
    [No Abstract]   [Full Text] [Related]  

  • 32. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Australian Perspectives on the Ethical and Regulatory Considerations for Responsible Data Sharing in Response to the COVID-19 Pandemic.
    Nicol D; Chalmers D; Critchley C; Eckstein L; Nielsen J; Otlowski M
    J Law Med; 2020 Aug; 27(4):829-838. PubMed ID: 32880401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Publishing research during pandemics: are you vulnerable to the COVID-19 or predatory publishers?
    Memon AR; Rathore FA
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S166-S168. PubMed ID: 32515402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open science approaches to COVID-19.
    Tse EG; Klug DM; Todd MH
    F1000Res; 2020; 9():1043. PubMed ID: 33145011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In the Turkish News: Coronavirus and "Alternative & complementary" medicine methods.
    Konakci G; Ozgursoy Uran BN; Erkin O
    Complement Ther Med; 2020 Sep; 53():102545. PubMed ID: 33066867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perils of Precipitate Publication: Fraudulent and Substandard COVID-19 Research.
    Freckelton I
    J Law Med; 2020 Aug; 27(4):779-789. PubMed ID: 32880397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timely access to trial data in the context of a pandemic: the time is now.
    Li R; Wood J; Baskaran A; Neumann S; Graham E; Levenstein M; Sim I
    BMJ Open; 2020 Oct; 10(10):e039326. PubMed ID: 33122319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achievements of the COVID-19 Turkey Platform in vaccine and drug development with an approach of "co-creation and succeeding together".
    Mandal H
    Turk J Med Sci; 2021 Dec; 51(SI-1):3139-3149. PubMed ID: 34921721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Other Side of the Coin: Risks of Media Discussions of Scientific Medical Data During the COVID-19 Pandemic.
    Fernandes CJ; Ganem F; Olivieri FG; Vilibor MF; Helito AS
    Arq Bras Cardiol; 2020 Aug; 115(2):278-280. PubMed ID: 32876197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.